Thank you
This live web event has ended. Thank you for attending.
Description
MyPath Melanoma: A 23-gene expression profile test to achieve diagnostic clarity in challenging melanocytic lesions
Why should you register now for this webinar?
- Hear a national thought leader discuss the accuracy and importance of MyPath Melanoma clinical validation
- Presenter: Matthew Goldberg, MD
- Moderated by: Bob McGonnagle, Publisher, CAP TODAY
What will this webinar empower you to do?
- Review of clinical and histopathological scenarios in which ancillary GEP can aid pathologists in the diagnostic work-up of melanocytic lesions
- Explanation of gene expression profiling and its use in the differentiation of benign nevi from malignant melanoma
- Overview of supporting data, performance metrics, guidelines, and clinical utility of MyPath Melanoma GEP testing
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Castle Biosciences.